RecallHawk

OCTREOTIDE ACETATE

WEST-WARD PHARMS INT

Summary

FDA approved OCTREOTIDE ACETATE by WEST-WARD PHARMS INT. ANDA (Generic) approval (Labeling) on 2022-09-16. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

ANDA076313-19

Action Date

2022-09-16

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

OCTREOTIDE ACETATE, INJECTABLE, INJECTION. Application: ANDA076313

Context & Analysis

WEST-WARD PHARMS INT has 2 FDA actions in our database.

Frequently Asked Questions

How often does WEST-WARD PHARMS INT have FDA actions?

WEST-WARD PHARMS INT has 2 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA076313-19" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions